The current data indicate that AMPK signaling in VSMCs inhibits phenotypic switching to a macrophage-like phenotype, reducing plaque instability and calcification, and therefore acting protectively in atherosclerosis. This evidence concerns the gene PRKAA2 and atherosclerosis.